Plasma Concentrations, Renal Excretion, and Tissue Release of Prostaglandins in the Rat with Dexamethasone-Induced Hypertension*
- 1 March 1984
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 114 (3), 1033-1040
- https://doi.org/10.1210/endo-114-3-1033
Abstract
It was investigated whether the hypertension produced by dexamethasone in the rat is associated with a deficit in circulating and renal prostaglandin E2 (PGE2) and PGI2, PG that are presumed to contribute to antihypertensive mechanisms. The administration of dexamethasone (2.5 mg kg-1 wk-1, s.c.) increased systolic blood pressure by 41 .+-. 6 mm Hg (P < 0.05) after 14 days of treatment, associated with elevations of urine volume and fluid intake, and loss of body wt. The glucocorticoid, however, had no effect on the plasma concentration, urinary excretion or vascular and renal tissue release of immunoreactive 6-keto-PGF1.alpha., a PGI2 metabolite. In contrast, dexamethasone increased (P < 0.05) the plasma PGE2 concentration by 157% and PGE2 urinary excretion by 134% after 14 days of treatment. However, the basal release of immunoreactive PGE2 as well as the angiotensin II-induced release of radiolabeled arachidonic acid and PG from renal medulla slices incubated in Krebs solution were diminished in rats receiving dexamethasone. The steroid also reduced to .apprx. 60% (P < 0.05) of the control value the activity in renal homogenates of 15-hydroxyprostaglandin dehydrogenase (PGDH), a major PG-catabolizing enzyme, without affecting the activity of the enzyme in the lung. Hence, the increased plasma concentration and renal excretion of PGE2 caused by dexamethasone in the face of reduced renomedullary production of the PG is presumably related to diminished degradation in the kidney and perhaps in other extrapulmonary tissues. The hypertension induced by dexamethasone in the rat is not associated with a deficit in circulating and renal PGE2, and PGI2.This publication has 13 references indexed in Scilit:
- Renal prostaglandin excretion and metabolism in male and female New Zealand normotensive and genetically hypertensive rats.Hypertension, 1981
- Anti-inflammatory steroids reduce tissue PG synthetase activity and enhance PG breakdownNature, 1980
- Effect of converting enzyme inhibition on glucocorticoid hypertension in the ratAmerican Journal of Physiology-Heart and Circulatory Physiology, 1980
- A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids.Proceedings of the National Academy of Sciences, 1980
- Regulation of prostaglandin E2 synthesis by angiotensin II, potassium, osmolality, and dexamethasoneKidney International, 1980
- Comparison of the Effects of ‘Glucocorticoid’ And ‘Mineralocortocoid’ Infusions on Blood Pressure in SheepClinical and Experimental Hypertension, 1979
- Evidence for an Angiotensinogenic Mechanism of the Hypertension of Cushing's Syndrome*Journal of Clinical Endocrinology & Metabolism, 1978
- ON LOCALIZATION OF A PROSTAGLANDIN-DEHYDROGENASE ACTIVITY IN KIDNEY1968
- Depletion of Carcass Potassium in Rats Made Hypertensive With Desoxycorticosterone Acetate (DCA) and With CortisoneJCI Insight, 1957
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951